In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors

Mu, Linjing; Honer, Michael; Becaud, Jessica; Martic, Miljen; Schubiger, Pius A; Ametamey, Simon M; Stellfeld, Timo; Graham, Keith; Borkowski, Sandra; Lehmann, Lutz; Dinkelborg, Ludger; Srinivasan, Ananth (2010). In vitro and in vivo characterization of novel 18F-labeled bombesin analogues for targeting GRPR-positive tumors. Bioconjugate chemistry, 21(10), pp. 1864-71. Washington, D.C.: American Chemical Society 10.1021/bc100222u

Full text not available from this repository. (Request a copy)

The gastrin-releasing peptide receptor (GRPR) is overexpressed on a number of human tumors and has been targeted with radiolabeled bombesin analogues for the diagnosis and therapy of these cancers. Seven bombesin analogues containing various linkers and peptide sequences were designed, synthesized, radiolabeled with (18)F, and characterized in vitro and in vivo as potential PET imaging agents. Binding studies displayed nanomolar binding affinities toward human GRPR for all synthesized bombesin analogues. Two high-affinity peptide candidates 6b (K(i) = 0.7 nM) and 7b (K(i) = 0.1 nM) were chosen for further in vivo evaluation. Both tracers revealed specific uptake in GRPR-expressing PC-3 tumors and the pancreas. Compared to [(18)F]6b, compound [(18)F]7b was characterized by superior tumor uptake, higher specificity of tracer uptake, and more favorable tumor-to-nontarget ratios. In vivo PET imaging allowed for the visualization of PC-3 tumor in nude mice suggesting that [(18)F]7b is a promising PET tracer candidate for the diagnosis of GRPR-positive tumors in humans.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic and Policlinic for Anaesthesiology and Pain Therapy

UniBE Contributor:

Lehmann, Lutz Eric




American Chemical Society




Jeannie Wurz

Date Deposited:

04 Oct 2013 14:08

Last Modified:

23 Jan 2018 12:17

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 199730)

Actions (login required)

Edit item Edit item
Provide Feedback